Vera’s $300M offering; Abeona resubmits treatment for rare skin disease

Plus, news about Astellas, Clover, ElevateBio, Monopar, Idorsia and Neurocrine Biosciences:

Vera Therapeutics plans $300M offering: The California biotech is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Morning Rounds: Have regulations on digital trackers in health care gone too far?

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Today we have Andrew Joseph’s

December 19, 2023

Amid backlash, Novo Nordisk reports positive cardiovascular profile for Wegovy – Pharmaceutical Technology

Considering the positive data, Novo Nordisk is planning to file for Wegovy’s label expansion in both the US and the European Union (EU) in 2023.

August 8, 2023

Opinion | What to Expect After the Kansas City Pharmacy Walkouts

The author is a pharmacist. If you’ve visited a big-chain pharmacy recently you may have experienced massive delays in filling your prescription. Promised wait times

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.